Gemigliptin
id:
gemigliptin-324-10643723
title:
Gemigliptin
text:
Gemigliptin (rINN), sold under the brand name Zemiglo, is an oral anti-hyperglycemic agent of the dipeptidyl peptidase-4 inhibitor class of drugs. Glucose lowering effects of DPP-4 inhibitors are mainly mediated by GLP-1 and gastric inhibitory polypeptide (GIP) incretin hormones which are inactivated by DPP-4. Gemigliptin was initially developed solely by LG Life Sciences. In 2010, Double-Crane Pharmaceutical Co. (DCPC) joined with LGLS to co-develop the final compound and collaborate on the mar
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Gemigliptin
date created:
date modified:
2024-01-04T10:32:17Z
main entity:
{"identifier":"Q5530612","url":"https://www.wikidata.org/entity/Q5530612"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b6/Structure_of_gemigliptin_%28LC15-0444%29.svg","width":673,"height":415}
fields total:
13
integrity:
15